Extended Viewer
Vaccine Mandates and Walmart’s Insulin
24 mins listen August 06, 2021
Some companies are mandating their employees receive vaccine for COVID-19 if they want to continue working at the company. The idea sort of seems like a mandatory health and safety procedure, albeit one with a bit more controversy surrounding it than others. Still, the companies that have a fully vaccinated workforce may be in a better place come winter than those without. We discuss how vaccine mandates are similar to the proactive health and safety policies implemented at companies in more dangerous industries. Then we ask whether Walmart has become a social impact company with its new relatively low-cost insulin product offered to uninsured Americans.
Featuring
Samuel Block
Vice President, ESG Research
Namita Nair
Vice President, MSCI Research
Related content
ESG Now Podcast
ESG explored. A rotating cast of researchers on environmental, social, and governance issues join hosts Mike Disabato and Bentley Kaplan as they discuss the most pressing news of the week. But in an enjoyable way.
Previous EpisodesThe Doctor Is Making House Calls: Capturing Exposure to Telehealth
Telehealth is rapidly redefining the mix of health-care delivery systems in many countries, having gotten a major boost during the COVID-19 pandemic.
Read the BlogMSCI ESG Healthcare Funds and SDG 3
We find that only 47 funds that invest globally in healthcare and allied industries had greater than 50% alignment with SDG 3, comprising just 0.51% of all healthcare funds and 15% of total healthcare fund assets.
Access Report